Treatment of vascular hyperpermeability in patients with sepsis and septic shock. research hub

A study to test a single administration of three dose levels of ATX101 in healthy adults.

This study is looking at a new medicine called ATX101. It's for adults with severe infections (sepsis). Researchers want to see how different small doses of this medicine work in healthy people to eventually help those who are very ill.